Role of the AMPK/SREBP-1 pathway in the development of orotic acid-induced fatty liver

Journal of Lipid Research

Volumn 52, Issue 9, 2011, Pages 1617-1625

  Jung, Eun Jeong ^a   Kwon, Sung Won ^a   Jung, Byung Hwa ^b   Oh, Seon Hee ^c   Lee, Byung Hoon ^a  

^a Seoul National University   (South Korea)

^b Korea Institute of Science and Technology   (South Korea)

^c Chosun University   (South Korea)

Author keywords

Adenosine monophosphate activated protein kinase; Lipids; Pharmacology; Sterol regulatory element binding protein 1; Toxicology

Indexed keywords

ADENYLATE KINASE; AMINOIMIDAZOLE CARBOXAMIDE RIBONUCLEOTIDE; METFORMIN; OROTIC ACID; PROTEIN KINASE LKB1; RAPAMYCIN; RIBONUCLEOTIDE; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; ENZYME REPRESSION; FATTY LIVER; FOOD INTAKE; GENE FUNCTION; GENE OVEREXPRESSION; HEPATOMA CELL; HUMAN; HUMAN CELL; IN VIVO STUDY; LIPID STORAGE; LIVER CELL; MALE; MOLECULAR PATHOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; RAT; TRANSCRIPTION INITIATION;

AMP-ACTIVATED PROTEIN KINASES; ANIMALS; CELL LINE; ENZYME ACTIVATION; FATTY LIVER; GENE EXPRESSION REGULATION; HEPATOCYTES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MICE; MICE, INBRED C57BL; OROTIC ACID; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN-SERINE-THREONINE KINASES; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; SIROLIMUS; STEROL REGULATORY ELEMENT BINDING PROTEIN 1;

EID: 80051820360     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M015263     Document Type: Article

References (48)

1. Standerfer, S B, and P. Handler. 1955. Fatty liver induced by orotic acid feeding. Proc. Soc. Exp. Biol. Med. 90: 270-271.
2. Ferreira, A V, G G Parreira, L C Porto, E G Mario, H L Delpuerto, A S Martins, and L M Botion. 2008. Fenofibrate prevents orotic acid-induced hepatic steatosis in rats. Life Sci. 82: 876-883.
3. Buang, Y., Y M Wang, J Y Cha, K. Nagao, and T. Yanagita. 2005. Dietary phosphatidylcholine alleviates fatty liver induced by orotic acid. Nutrition. 21: 867-873. (Pubitemid 40828812)
4. Miyazawa, S., S. Furuta, and T. Hashimoto. 1982. Reduction of beta-oxidation capacity of rat liver mitochondria by feeding orotic acid. Biochim. Biophys. Acta. 711: 494-502.
5. Hebbachi, A M, M C Seelaender, B W Baker, and G F Gibbons. 1997. Decreased secretion of very-low-density lipoprotein triacylglycerol and apolipoprotein B is associated with decreased intracellular triacylglycerol lipolysis in hepatocytes derived from rats fed orotic acid or n-3 fatty acids. Biochem. J. 325: 711-719.
6. Durschlag, R P, and J L Robinson. 1980. Species specificity in the metabolic consequences of orotic acid consumption. J. Nutr. 110: 822-828. (Pubitemid 10033298)
7. Hawley, S A, M. Davison, A. Woods, S P Davies, R K Beri, D. Carling, and D G Hardie. 1996. Characterization of the AMPactivated protein kinase kinase from rat liver and identification of threonine 172 as the major site at which it phosphorylates AMP-activated protein kinase. J. Biol. Chem. 271: 27879-27887. (Pubitemid 26367365)
8. Hardie, D G, J. Corton, Y P Ching, S P Davies, and S. Hawley. 1997. Regulation of lipid metabolism by the AMP-activated protein kinase. Biochem. Soc. Trans. 25: 1229-1231. (Pubitemid 27528568)
9. Kawanaka, K., L A Nolte, D H Han, P A Hansen, and J O Holloszy. 2000. Mechanisms underlying impaired GLUT-4 translocation in glycogen-supercompensated muscles of exercised rats. Am. J. Physiol. Endocrinol. Metab. 279: E1311-E1318.
10. Taylor, E B, W J Ellingson, J D Lamb, D G Chesser, and W W Winder. 2005. Long-chain acyl-CoA esters inhibit phosphorylation of AMP-activated protein kinase at threonine-172 by LKB1/STRAD/MO25. Am. J. Physiol. Endocrinol. Metab. 288: E1055-E1061. (Pubitemid 40726790)
11. Rafaeloff-Phail, R., L. Ding, L. Conner, W K Yeh, D. McClure, H. Guo, K. Emerson, and H. Brooks. 2004. Biochemical regulation of mammalian AMP-activated protein kinase activity by NAD and NADH. J. Biol. Chem. 279: 52934-52939. (Pubitemid 40051792)
12. Fryer, L G D, A. Parbu-Patel, and D. Carling. 2002. The anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct signaling pathways. J. Biol. Chem. 277: 25226-25232. (Pubitemid 34951829)
13. Minokoshi, Y., Y B Kim, O D Peroni, L G Fryer, C. Müller, D. Carling, and B B Kahn. 2002. Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase. Nature. 415: 339-343. (Pubitemid 34087557)
14. Hawley, S A, J. Boudeau, J L Reid, K J Mustard, L. Udd, T P Mäkelä, D R Alessi, and D G Hardie. 2003. Complexes between the LKB1 tumor suppressor, STRADalpha/beta and MO25alpha/beta are upstream kinases in the AMP-activated protein kinase cascade. J. Biol. 2: 28-32.
15. Branvold, D J, D R Allred, D J Beckstead, H J Kim, N. Fillmore, B M Condon, J D Brown, S N Sudweeks, D M Thomson, and W W Winder. 2008. Thyroid hormone effects on LKB1, MO25, phospho-AMPK, phospho-CREB, and PGC-1α in rat muscle. J. Appl. Physiol. 105: 1218-1227.
16. Porstmann, T., C R Santos, B. Griffiths, M. Cully, M. Wu, S. Leevers, J R Griffiths, Y L Chung, and A. Schulze. 2008. SREBP activity is regulated by mTORC1 and contributes to Akt-dependent cell growth. Cell Metab. 8: 224-236.
17. You, M., M. Matsumoto, C M Pacold, W K Cho, and D W Crabb. 2004. The role of AMP-activated protein kinase in the action of ethanol in the liver. Gastroenterology. 127: 1798-1808. (Pubitemid 39575858)
18. Yuan, H., J Y J Shy, and M. Martins-Green. 2009. Second-hand smoke stimulates lipid accumulation in the liver by modulating AMPK and SREBP-1. J. Hepatol. 51: 535-547.
19. Wu, Y., P. Song, J. Xu, M. Zhang, and M H Zou. 2007. Activation of protein phosphatase 2A by palmitate inhibits AMP-activated protein kinase. J. Biol. Chem. 282: 9777-9788. (Pubitemid 47104626)
20. Lee, W J, M. Kim, H S Park, H S Kim, M J Jeon, K S Oh, E H Koh, J C Won, M S Kim, G T Oh, et al. 2006. AMPK activation increases fatty acid oxidation in skeletal muscle by activating PPARα and PGC-1. Biochem. Biophys. Res. Commun. 340: 291-295. (Pubitemid 41827679)
21. Kelley, W N, M L Greene, I H Fox, F M Rosenbloom, R I Levy, and J E Seegmiller. 1970. Effects of orotic acid on purine and lipoprotein metabolism in man. Metabolism. 19: 1025-1035.
22. Griffin, J L, S A Bonney, C. Mann, A M Hebbachi, G F Gibbons, J K Nicholson, C C Shoulders, and J. Scott. 2004. An integrated reverse functional genomic and metabolic approach to understanding orotic acid-induced fatty liver. Physiol. Genomics. 17: 140-149. (Pubitemid 38924160)
23. French, C T, W H Hanneman, L S Chubb, R E Billings, and M E Andersen. 2004. Induction of CYP1A1 in primary rat hepatocytes by 3,3′,4,4′,5- pentachlorobiphenyl: Evidence for a switch circuit element. Toxicol. Sci. 78: 276-286. (Pubitemid 38559676)
24. Honkakoski, P, and M. Negishi. 1998. Protein serine/threonine phosphatase inhibitors suppress phenobarbital-induced Cyp2b10 gene transcription in mouse primary hepatocytes. Biochem. J. 330: 889-895. (Pubitemid 28111993)
25. Wynants, J, and H. Van Belle. Single-run high-performance liquid chromatography of nucleotides, nucleosides, and major purine bases and its application to different tissue extracts. 1985. Anal. Biochem. 144: 258-266.
26. Wang, L H, Y L Choi, X Y Hua, Y K Shin, Y J Song, S J Youn, H Y Yun, S M Park, W J Kim, H J Kim, et al. 2006. Increased expression of sonic hedgehog and altered methylation of its promoter region in gastric cancer and its related lesions. Mod. Pathol. 19: 675-683.
27. Bruce, C R, M J Anderson, A L Carey, D G Newman, A. Bonen, A D Kriketos, G J Cooney, and J A Hawley. 2003. Muscle oxidative capacity is a better predictor of insulin sensitivity than lipid status. J. Clin. Endocrinol. Metab. 88: 5444-5451. (Pubitemid 37452752)
28. You, M., M. Fischer, M A Deg, and D W Crabb. 2002. Ethanol induces fatty acid synthesis pathways by activation of sterol regulatory element-binding protein (SREBP). J. Biol. Chem. 277: 29342-29347.
29. Stein, S C, A. Woods, N A Jones, M D Davison, and D. Carling. 2000. The regulation of AMP-activated protein kinase by phosphorylation. Biochem. J. 345: 437-443. (Pubitemid 30099070)
30. Zhou, G., R. Myers, Y. Li, Y. Chen, X. Shen, J. Fenyk-Melody, M. Wu, J. Ventre, T. Doebber, N. Fujii, et al. 2001. Role of AMP-activated protein kinase in mechanism of metformin action. J. Clin. Invest. 108: 1167-1174. (Pubitemid 32995375)
31. Shklyaev, S., G. Aslanidi, M. Tennant, V. Prima, E. Kohlbrenner, V. Kroutov, M. Campbell-Thompson, J. Crawford, E W Shek, P J Scarpace, et al. 2003. Sustained peripheral expression of transgene adiponectin offsets the development of diet-induced obesity in rats. Proc. Natl. Acad. Sci. USA. 100: 14217-14222. (Pubitemid 37499217)
32. Boudeau, J., M. Deak, M A Lawlor, N A Morrice, and D R Alessi. 2003. Heat-shock protein 90 and Cdc37 interact with LKB1 and regulate its stability. Biochem. J. 370(Pt. 3): 849-857. (Pubitemid 36399076)
33. Creasey, W A, L. Hankin, and R E Handschumacher. 1961. Fatty livers induced by orotic acid. J. Biol. Chem. 236: 2064-2070.
34. Brown, E J, P A Beal, C T Keith, J. Chen, T B Shin, and S L Schreiber. 1995. Control of p70S6 kinase by kinase activity of FRAP in vivo. Nature. 377: 441-446.
35. Hwahng, S H, S H Ki, E J Bae, H E Kim, and S G Kim. 2009. Role of adenosine monophosphate-activated protein kinase-p70 ribosomal S6 kinase-1 pathway in repression of liver X receptor-alpha-dependent lipogenic gene induction and hepatic steatosis by a novel class of dithiolethiones. Hepatology. 49: 1913-1925.
36. Hurlbert, R B, and V R Potter. 1954. Nucleotide metabolism. J. Biol. Chem. 209: 1-21.
37. Richards, S M, R A J Conyers, J L Fisher, and F L Rosenfeldt. 1997. Cardioprotection by orotic acid: Metabolism and mechanism of action. J. Mol. Cell. Cardiol. 29: 3239-3250. (Pubitemid 28039358)
38. Robinson, J L 1980. Bovine milk orotic acid: Variability and significance for human nutrition. J. Dairy Sci. 63: 865-871.
39. Dufner, A, and G. Thomas. 1999. Ribosomal S6 kinase signaling and the control of translation. Exp. Cell Res. 253: 100-109.
40. Gingras, A C, B. Raught, and N. Sonenberg. 2004. mTOR signaling to translation. Curr. Top. Microbiol. Immunol. 279: 169-197. (Pubitemid 37047263)
41. Vinciguerra, M., C. Veyrat-Durebex, M A Moukil, L. Rubbia- Brandt, F. Rohner-Jeanrenaud, and M. Foti. 2008. PTEN downregulation by unsaturated fatty acids triggers hepatic steatosis via an NF-kappaBp65/mTOR-dependent mechanism. Gastroenterology. 134: 268-280. (Pubitemid 350309315)
42. Mordier, S, and P B Iynedjian. 2007. Activation of mammalian target of rapamycin complex 1 and insulin resistance induced by palmitate in hepatocytes. Biochem. Biophys. Res. Commun. 362: 206-211. (Pubitemid 47296312)
43. Syed, D N, F. Afaq, M H Kweon, N. Hadi, N. Bhatia, V S Spiegelman, and H. Mukhtar. 2007. Green tea polyphenol EGCG suppresses cigarette smoke condensate-induced NF-kappaB activation in normal human bronchial epithelial cells. Oncogene. 26: 673-682. (Pubitemid 46204247)
44. Xu, C F, C H Yu, L. Xu, M. Miao, and Y M Li. 2010. Is cigarette smoking an independent risk factor or a cofactor for nonalcoholic fatty liver disease? Hepatology. 52: 803-804.
45. Milner, J A, and A S Hassan. 1981. Species specificity of arginine deficiency-induced hepatic steatosis. J. Nutr. 111: 1067-1073. (Pubitemid 11034748)
46. Harrison, W J, J J Bull, H. Seltmann, C C Zouboulis, and M P Philpott. 2007. Expression of lipogenic factors galectin-12, resistin, SREBP-1, and SCD in human sebaceous glands and cultured sebocytes. J. Invest. Dermatol. 127: 1309-1317. (Pubitemid 46762995)
47. Sekiya, M., A. Hiraishi, M. Touyama, and K. Sakamoto. 2008. Oxidative stress induced lipid accumulation via SREBP1c activation in HepG2 cells. Biochem. Biophys. Res. Commun. 375: 602-607.
48. Howell 3rd, G., X. Deng, C. Yellaturu, E A Park, H G Wilcox, R. Raghow, and M B Elam. 2009. N-3 polyunsaturated fatty acids suppress insulin-induced SREBP-1c transcription via reduced trans-activating capacity of LXRα. Biochim. Biophys. Acta. 1791: 1190-1196.